Ran Zuo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Epithelial Mesenchymal Transition

Prognostic Factors

Top Venues

Thoracic cancer

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Dongming Liu, Ran Zuo, Wei Liu, Yuchao He, Yu Wang, Ping Yue, Wenchen Gong, Jinfang Cui, Fu-Yi Zhu, Yi Luo, Lisha Qi, Yan Guo, Liwei Chen, Guangtao Li, Zhiyong Liu, Peng Chen, Hua Guo
DNAJC24 acts directly with PCNA and promotes malignant progression of LUAD by activating phosphorylation of AKT. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (9) (2024)
Dongming Liu, Ran Zuo, Wei Liu, Yuchao He, Yu Wang, Ping Yue, Wenchen Gong, Jinfang Cui, Fu-Yi Zhu, Yi Luo, Lisha Qi, Yan Guo, Liwei Chen, Guangtao Li, Zhiyong Liu, Peng Chen, Hua Guo
DNAJC24 acts directly with PCNA and promotes malignant progression of LUAD by activating phosphorylation of AKT. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (9) (2024)
Ran Zuo, Fuyi Zhu, Cuicui Zhang, Jincheng Ma, Jinliang Chen, Ping Yue, Jinfang Cui, Yu Wang, Peng Chen
The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma. Thoracic cancer (2023)
Dongqi Yuan, Fuyi Zhu, Ran Zuo, Yu Wang, Gengwei Huo, Jinfang Cui, Ping Yue, Peng Chen
High incidence and reversible bradycardia events following alectinib initiation. Thoracic cancer (2022)
Dongqi Yuan, Fuyi Zhu, Ran Zuo, Yu Wang, Gengwei Huo, Jinfang Cui, Ping Yue, Peng Chen
High incidence and reversible bradycardia events following alectinib initiation. Thoracic cancer 14 (5) (2022)
Dongqi Yuan, Fuyi Zhu, Ran Zuo, Yu Wang, Gengwei Huo, Jinfang Cui, Ping Yue, Peng Chen
High incidence and reversible bradycardia events following alectinib initiation. Thoracic cancer 14 (5) (2022)
Ran Zuo, Cuicui Zhang, Li Lin, Zhaoting Meng, Yajie Wang, Yudong Su, Mihray Abudurazik, Ye Du, Peng Chen
Durable efficacy of anlotinib in a patient with advanced thymic squamous cell carcinoma after multiline chemotherapy and apatinib: A case report and literature review. Thoracic cancer 11 (11) (2020)